The Clinical Guidelines Committee of the American College of Physicians (ACP) has released a new clinical guideline on the ...

The ACP issued new clinical guidance on preventing episodic migraines, classified as one to 14 headache days per month, in ...

The American College of Physicians (ACP) has developed new recommendations to prevent episodic migraines in nonpregnant ...

With historical data showing migraine to be underdiagnosed and undertreated, new guidance from the American College of ...

A common drug used to prevent migraines might have an additional benefit -- protecting women against stroke.Women takin ...

Migraines affect millions worldwide, yet remain widely misunderstood. This neurological condition extends far beyond typical headache symptoms, often ...

Propranolol, a beta blocker medication used for treating high blood pressure and preventing migraines, may lower ischemic stroke risk in women who experience migraines frequently.

The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or ...

FDA approves Symbravo for acute migraine relief, combining rizatriptan and meloxicam. Discover its unique benefits and fast absorption for effective symptom control.

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

A medication often used to treat high blood pressure and prevent migraines was associated with a reduction in ischemic stroke risk among women using the drug for migraine prevention, according to a ...